Technical Analysis for HSDT - Helius Medical Technologies, Inc.

Grade Last Price % Change Price Change
grade F 0.6 -16.67% -0.12
HSDT closed down 16.67 percent on Wednesday, November 20, 2019, on 2.25 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical HSDT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -16.67%
Narrow Range Bar Range Contraction -16.67%
NR7 Range Contraction -16.67%
Wide Bands Range Expansion -16.67%
Oversold Stochastic Weakness -16.67%

Older signals for HSDT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
HSDT Chart by TradingView
Basic chart:
Profile
Helius Medical Technologies is a medical technology company focused on neurological wellness. Helius seeks to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself.
Medical Technology
Is HSDT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 18 Did Changing Sentiment Drive Helius Medical Technologies's (NASDAQ:HSDT) Share Price Down A Painful 94%?
Nov 13 The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Nov 12 Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q3 2019 Results - Earnings Call Transcript
Nov 12 Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Misses Revenue Estimates
Nov 12 The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
Nov 12 Helius Medical Technologies EPS in-line, misses on revenue
Nov 12 Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook
Oct 24 Helius Medical Technologies, Inc. Announces Update on US Regulatory Strategy Following Pre-Submission Meeting with FDA
Oct 11 The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
Oct 1 The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
See more HSDT news...
Indicators
Indicator Value
52 Week High 10.67
52 Week Low 0.58
Average Volume 37,605
200-Day Moving Average 3.08
50-Day Moving Average 1.4582
20-Day Moving Average 1.1198
10-Day Moving Average 0.8441
Average True Range 0.1186
ADX 51.27
+DI 5.1969
-DI 40.0819
Chandelier Exit (Long, 3 ATRs ) 1.3342
Chandelier Exit (Short, 3 ATRs ) 0.9358
Upper Bollinger Band 1.7279
Lower Bollinger Band 0.5117
Percent B (%b) 0.07
BandWidth 108.60868
MACD Line -0.2373
MACD Signal Line -0.1982
MACD Histogram -0.0391
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.81
Resistance 3 (R3) 0.83 0.77 0.78
Resistance 2 (R2) 0.77 0.72 0.77 0.76
Resistance 1 (R1) 0.69 0.69 0.66 0.67 0.75
Pivot Point 0.63 0.63 0.62 0.63 0.63
Support 1 (S1) 0.55 0.58 0.52 0.53 0.45
Support 2 (S2) 0.49 0.55 0.49 0.44
Support 3 (S3) 0.41 0.49 0.43
Support 4 (S4) 0.39